Yepbio
Anyang · Founded 2018
About Yepbio
Yebio develops drugs and biomarkers for degenerative brain diseases, as well as diagnostic kits and biomarkers for early diagnosis of these diseases. Yebio supplies the energy for life in the super-aging era.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $790.2K
- Last round: Grant (Dec 2024)
- Website: yepbio.com
- Phone: +82 031-337-7191
Industries & Categories
Biopharma, Health Care, Medical
Canonical: https://fsome.com/organization/yepbio-980337 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.